Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 12 results for "dcgi"

Hetero gets DCGI nod for generic chronic hepatitis C drug

Drug firm Hetero today said it has received nod from the regulator DCGI for its generic Sofosbuvir and Velpatasvir combination tablets used for treatment of chronic hepatitis C. DNA, 3 weeks ago

4 images for dcgi

Money Control, 2 months ago
Livemint.com, 3 months ago
Indian Express, 4 months ago
Indian Express, 7 months ago

Regenerative Medical Services receives DCGI nod for cell therapy product

Chondron ACI is indicated for use of articular cartilage defects of knee, ankle & shoulder joints BS B2B Bureau | Mumbai April 13, 2017 Last Updated at 16:04 IST The Mumbai-based Regenerative Medical Services Regrow (RMS Regrow) has received market ...
 Business Standard1 month ago

The division bench did not approve of the single judge's

The division bench today said the directions given to DCGI by the single judge shall not be operational till the next date of hearing.
 DNA2 months ago
Money Control

Biocon, Mylan breast cancer drugs approved by DCGI: HC told

Swiss pharma major Roche cannotprima facie have a say against the sale and marketing ofbreast cancer medicines of drug firms Biocon and Mylan oncethe Drugs Controller General of India (DCGI) has approved it,Delhi High Court said today.
 Money Control2 months ago
[x]  

CCI order against Roche is anti-competition: HC

The Delhi High Court on Wednesday termed as "anti-competition and anti-legal right", a Competition Commission of India's (CCI) order initiating an inquiry into the alleged abuse of dominant position by Swiss drug major Roche. Justice Sanjeev Sachdeva said the ...
 The Financial Chronicle1 day ago

Govt invokes emergency clause to maintain supply of stents

The government has asked stent manufacturers to maintain uninterrupted supply of coronary stents by invoking emergency clause in public interest. The move comes in the wake of various multinationals, including Abbott Healthcare and India Medtronic, seeking ...
 Deccan Herald1 month ago

HC allows Biocon, Mylan to sell their drug for three cancers

The Delhi High Court today allowed drug companies Biocon and Mylan to sell their version of Trastuzumab for two kinds of breast cancer and metastatic gastric cancer in view of the approval granted to it by the Drugs Controller General of India (DCGI).
 DNA2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less